Squarepoint
HOOK

Squarepoint’s HOOKIPA Pharma HOOK Stock Holding History

Squarepoint’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40,808
Closed -$44.1K – 4720
2025
Q1 		$44.1K Sell
40,808
-11,152
-21% -$18.4K ﹤0.01% 4362
2024
Q4 		$104K Buy
+51,960
New +$161K ﹤0.01% 4687
2022
Q2 		– Sell
-1,374
Closed -$31K – 3077
2022
Q1 		$31K Buy
+1,374
New +$24.6K ﹤0.01% 2698
2020
Q4 		– Sell
-1,270
Closed -$120K – 3055
2020
Q3 		$120K Sell
1,270
-1,058
-45% -$108K ﹤0.01% 2244
2020
Q2 		$270K Buy
2,328
+248
+12% +$24.2K ﹤0.01% 1668
2020
Q1 		$172K Buy
+2,080
New +$228K ﹤0.01% 1524

Other funds holding HOOK

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Squarepoint's HOOK Position: Q2 2025 in Review

Squarepoint sold out of HOOKIPA Pharma (HOOK) in Q2 2025, closing a stake of 40,808 shares — an estimated $44.1K sold.

Squarepoint first reported a position in HOOK in Q1 2020 and held it in 6 quarters. The position peaked at $270K in Q2 2020. 27 funds tracked by Wall St. Rank hold HOOK as of Q2 2025.

  • Squarepoint reported no remaining HOOKIPA Pharma position as of Q2 2025 after selling out during the quarter.
  • Squarepoint sold 40,808 HOOKIPA Pharma shares in Q2 2025, an estimated $44.1K.
  • Squarepoint first reported a position in HOOKIPA Pharma in Q1 2020 and held it in 6 quarters.
  • Squarepoint's HOOKIPA Pharma position peaked at $270K in Q2 2020.
  • 27 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q2 2025.

Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.